Skip to main navigation
Header Menu
  • About Us
    • Who We Are
    • Our Team
    • Board of Directors
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
    • Clinical Trials
    • Research
  • Products
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
    • Pear Prescription Digital Therapeutics (PDT) Digest
  • Investors
    • IR Home
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Top Links
Contact Us
Pear Therapeutics, Inc.

SEC Filing Details

IR Sub Menu - Financial Information
SEC FilingsQuarterly ResultsAnnual Reports

Document Details

Form
8-K
Filing Date
June 24, 2022
Document Date
June 24, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Pear Therapeutics, Inc.
Issuer
PEAR THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

 

Back
Pear Therapeutics, Inc.
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
Footer Email
  • Email Us
Footer Social
  • Twitter
  • LinkedIn
  • © 2023 Pear Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct